Diprivan (General Injectables & Vaccines, Inc)


Welcome to the PulseAid listing for the Diprivan drug offered from General Injectables & Vaccines, Inc. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: General Injectables & Vaccines, Inc
NON-PROPRIETARY NAME: Diprivan
SUBSTANCE NAME: PROPOFOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: General Anesthesia [PE],General Anesthetic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, EMULSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-03-01
END MARKETING DATE: 0000-00-00


Diprivan HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDiprivan from General Injectables & Vaccines, Inc
LABELER NAME: General Injectables & Vaccines, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2010-03-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52584-269_bc7ce430-9a37-4654-b256-3a7ef0643e9b
PRODUCT NDC: 52584-269
APPLICATION NUMBER: NDA019627

Other PROPOFOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Propofol
APP Pharmaceuticals, LLCPropofol
Fresenius Kabi USA, LLCDiprivan
General Injectables & Vaccines, IncDiprivan
General Injectables and Vaccines, IncPropofol
Hospira, Inc.PROPOFOL
Sagent Pharmaceuticalspropofol